Jain Global’s Stoke Therapeutics STOK Stock Holding History

Jain Global’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,340	Closed	-$572K	–	1502
2025 Q3	$572K	Buy	+24,340	New	+$417K	﹤0.01%	721

Other funds holding STOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jain Global's STOK Position: Q4 2025 in Review

Jain Global sold out of Stoke Therapeutics (STOK) in Q4 2025, closing a stake of 24,340 shares — an estimated $572K sold.

Jain Global first reported a position in STOK in Q3 2025 and held it in 1 quarter. The position peaked at $572K in Q3 2025. 183 funds tracked by Wall St. Rank hold STOK as of Q4 2025.

Jain Global reported no remaining Stoke Therapeutics position as of Q4 2025 after selling out during the quarter.
Jain Global sold 24,340 Stoke Therapeutics shares in Q4 2025, an estimated $572K.
Jain Global first reported a position in Stoke Therapeutics in Q3 2025 and held it in 1 quarter.
Jain Global's Stoke Therapeutics position peaked at $572K in Q3 2025.
183 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.